108 related articles for article (PubMed ID: 29038419)
21. Differential effects of cyclosporin and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants.
Bicknell GR; Williams ST; Shaw JA; Pringle JH; Furness PN; Nicholson ML
Br J Surg; 2000 Nov; 87(11):1569-75. PubMed ID: 11091247
[TBL] [Abstract][Full Text] [Related]
22. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
23. MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
Wieczorek E; Jablonowski Z; Tomasik B; Konecki T; Jablonska E; Gromadzinska J; Fendler W; Sosnowski M; Wasowicz W; Reszka E
Clin Biochem; 2015 Dec; 48(18):1235-40. PubMed ID: 26197083
[TBL] [Abstract][Full Text] [Related]
24. ADAMTS1 is regulated by interleukin-1beta, not by hypoxia, in chondrosarcoma.
Kalinski T; Krueger S; Sel S; Werner K; Röpke M; Roessner A
Hum Pathol; 2007 Jan; 38(1):86-94. PubMed ID: 16949904
[TBL] [Abstract][Full Text] [Related]
25. Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma.
Yang HK; Jeong KC; Kim YK; Jung ST
Clin Orthop Surg; 2014 Dec; 6(4):443-54. PubMed ID: 25436070
[TBL] [Abstract][Full Text] [Related]
26. The role of matrix metalloproteinase MMP-9 and TIMP-2 tissue inhibitor of metalloproteinases as serum markers of bladder cancer.
Ramón de Fata F; Ferruelo A; Andrés G; Gimbernat H; Sánchez-Chapado M; Angulo JC
Actas Urol Esp; 2013 Sep; 37(8):480-8. PubMed ID: 23916137
[TBL] [Abstract][Full Text] [Related]
27. The Role of ADAMTS1 and Versican in Human Myocardial Infarction: A Postmortem Study.
Pehlivan S; Gurses MS; Ural MN; Akyol S; Eren F; Turkmen Inanir N; Gulec MA; Eren B; Fedakar R; Demircan K; Akyol O
Lab Med; 2016 Aug; 47(3):205-12. PubMed ID: 27346868
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Value of ADAMTS Proteases and Their Substrates in Epithelial Ovarian Cancer.
Lima MA; Dos Santos L; Turri JA; Nonogaki S; Buim M; Lima JF; de Jesus Viana Pinheiro J; Bueno de Toledo Osório CA; Soares FA; Freitas VM
Pathobiology; 2016; 83(6):316-26. PubMed ID: 27359117
[TBL] [Abstract][Full Text] [Related]
29. rs3918242 variant genotype frequency and increased TIMP-2 and MMP-9 expression are positively correlated with cancer invasion in urinary bladder cancer.
Pençe S; Özbek E; Ozan Tiryakioğlu N; Ersoy Tunali N; Pençe HH; Tunali H
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):46-52. PubMed ID: 28980922
[TBL] [Abstract][Full Text] [Related]
30. Expressions of Matrix Metalloproteinases-9 and Tissue Inhibitor of Metalloproteinase-1 in Pituitary Adenomas and Their Relationships with Prognosis.
Guo H; Sun Z; Wei J; Xiang Y; Qiu L; Guo L; Zhao W; Xu Z; Mao J
Cancer Biother Radiopharm; 2019 Feb; 34(1):1-6. PubMed ID: 30676069
[TBL] [Abstract][Full Text] [Related]
31. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
32. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
33. High levels of tissue inhibitor of metalloproteinase-2 (TIMP-2) expression are associated with poor outcome in invasive bladder cancer.
Grignon DJ; Sakr W; Toth M; Ravery V; Angulo J; Shamsa F; Pontes JE; Crissman JC; Fridman R
Cancer Res; 1996 Apr; 56(7):1654-9. PubMed ID: 8603416
[TBL] [Abstract][Full Text] [Related]
34. Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas.
Krecicki T; Fraczek M; Jelen M; Podhorska M; Szkudlarek T; Zatonski T
Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):494-7. PubMed ID: 12739032
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.
Wild PJ; Herr A; Wissmann C; Stoehr R; Rosenthal A; Zaak D; Simon R; Knuechel R; Pilarsky C; Hartmann A
Clin Cancer Res; 2005 Jun; 11(12):4415-29. PubMed ID: 15958626
[TBL] [Abstract][Full Text] [Related]
36. Gene discovery in bladder cancer progression using cDNA microarrays.
Sanchez-Carbayo M; Socci ND; Lozano JJ; Li W; Charytonowicz E; Belbin TJ; Prystowsky MB; Ortiz AR; Childs G; Cordon-Cardo C
Am J Pathol; 2003 Aug; 163(2):505-16. PubMed ID: 12875971
[TBL] [Abstract][Full Text] [Related]
37. Imbalance between matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) contributes to bladder compliance changes in rabbits with partial bladder outlet obstruction (PBOO).
Yang L; Liu R; Wang X; He D
BJU Int; 2013 Aug; 112(4):E391-7. PubMed ID: 23305285
[TBL] [Abstract][Full Text] [Related]
38. Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium.
Toba H; de Castro Brás LE; Baicu CF; Zile MR; Lindsey ML; Bradshaw AD
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E1027-35. PubMed ID: 27143554
[TBL] [Abstract][Full Text] [Related]
39. Aberrant methylation of ADAMTS1 in non-small cell lung cancer.
Choi JE; Kim DS; Kim EJ; Chae MH; Cha SI; Kim CH; Jheon S; Jung TH; Park JY
Cancer Genet Cytogenet; 2008 Dec; 187(2):80-4. PubMed ID: 19027488
[TBL] [Abstract][Full Text] [Related]
40. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.
Kim TD; Song KS; Li G; Choi H; Park HD; Lim K; Hwang BD; Yoon WH
BMC Cancer; 2006 Aug; 6():211. PubMed ID: 16916471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
